Consumer Alert! Byetta Pancreatic Cancer Association
This is Michael Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm. First Actos was linked to bladder cancer, now Byetta to pancreatic cancer. The diabetes drug Byetta has a long history of safety problems ranging from pancreatitis to renal failure. However, the warnings signs have taken on an entirely different meaning in
Read MoreConsumer Alert! Propecia and Sexual Dysfunction
Propecia is a “vanity drug” used to treat male pattern baldness. At the 360 Advocacy Conference at which I lectured in Chicago back in April of this year, I presented to my attorney colleagues the growing scientific evidence of Propecia’s association with sexual dysfunction. The bad news is that mounting evidence supports the conclusion that
Read MoreThe Fight for the Actos MDL Heats Up
This is Michael Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm. As I predicted, the fight as to where the Actos bladder cancer MDL ends up just got a little more heated. Today, another dog entered the fight for the selection of MDL consolidation. An application was made to have the Actos
Read MoreConsumer Alert! More Bad News for Multaq
The news just keeps getting worse and worse for Multaq. Today the European Medicines Agency (EMA) expressed grave concerns over the safety of Multaq. This comes on the heels of highly vocal and pointed criticism of the safety profile of Multaq by Dr. Steve Nissen at the Cleveland Clinic. All of this, coupled with the
Read MoreConsumer Alert! Recalled Qualitest Birth Control Pills
If you are taking Qualitest Pharmaceuticals birth control pills, this is must-know information! Qualitest Pharmaceuticals is voluntarily recalling multiple lots of its birth control pills because of a packaging error that may leave women without adequate contraception and at risk for unintended pregnancy. It seems that the pill package was subject to a goof when
Read MoreMotion Filed to Consolidate Actos Bladder Cancer Cases in Illinois
This is Michael Brady Lynch, lead attorney for The Michael Brady Lynch Firm. I think this is a good development. In a somewhat unorthodox move given the relatively small number of cases on file, a motion to consolidate Actos bladder cancer cases for pre-trial proceedings and discovery before Judge G. Patrick Murphy in the Southern
Read MoreCancer Patients Taking Zofran Exposed to Fatal Heart Rhythms
This is Michael Brady Lynch, lead trial attorney at The Michael Brady Lynch Firm. Today, the FDA notified healthcare professionals and patients of an ongoing safety review and labeling changes for the anti-nausea drug Zofran. Zofran may increase the risk of developing prolongation of the QT interval of the electrocardiogram, which can lead to an
Read MoreByetta Linked to Cancer In Rat Studies
This bad news for consumers as well as bad news for Eli Lilly and Amlyn Pharmaceuticals. Recent studies have shown an increase of instances of thyroid cancer in rats treated with Byetta. It appears the drug may be following in the footsteps Novo Nordisk’s competing Victoza, which hold a similar warning. Granted, the Byetta dose
Read MoreFDA Considers 5 Year Limit on Fosamax Use
This is a long time coming. It is about time that the FDA is finally coming around to the notion that long-term use of bisphosphonates like Fosamax is just a bad idea. The simple fact is that the longer a person uses Fosamax, the greater the likelihood that he/she will suffer from a severe, disabling
Read MoreThe Michael Brady Lynch Firm Salutes the Fallen Heroes of 9/11
Today marks the 10-year anniversary of the 9/11 terrorist attacks. I think almost everyone can remember exactly what they were doing at the moment they heard that America was at war. Having been born and raised a youngster in New York City, the Twin Towers were always a magical sight to behold as both a
Read More